JW Pharmaceutical (South Korea)

Recent papers from JW Pharmaceutical (South Korea)

1. Abstract 4566: Discovery and characterization of CKD-9001, a novel PARP1-selective inhibitor and DNA trapper with enhanced efficacy and an improved toxicity profile in HRD cancersCancer Research · 2026
2. Clinical Impact of Postrecanalization Hemorrhagic Transformation and Its Prediction Using Baseline Noncontrast CTStroke · 2026
3. Cytokine release syndrome following chimeric antigen receptor T-cell therapy: Pathophysiology, clinical manifestations, and novel therapeutic approachesГематология и трансфузиология · 2025
4. Ruxolitinib Alleviates Inflammation and Fortifies Skin Barrier Function Through Dampening IL‐13Experimental Dermatology · 2025
5. Artificial Intelligence-Enhanced Analysis of Echocardiography-Based Radiomic Features for Myocardial Hypertrophy Detection and Etiology DifferentiationCirculation Cardiovascular Imaging · 2025
6. A Comparative Study of Septal Extension Graft versus Derotation Graft for Short Nose Correction in Asian RhinoplastyPlastic & Reconstructive Surgery · 2025
7. Development and Evaluation of the Global Appraisal of Individual Needs Quick Version 4 (GAIN-Q4) for ASAM Dimension Ratings and Placement Recommendations for Adolescents and AdultsJournal of Addiction Medicine · 2024
8. Prognostic Value of Pulmonary Artery Systolic Pressure in Severe Rheumatic Mitral StenosisCirculation Cardiovascular Imaging · 2024
9. Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacyJournal of drug targeting · 2024
10. Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic CancerJournal of Proteome Research · 2024
11. RORα–GABP–TFAM axis alleviates myosteatosis with fatty atrophy through reinforcement of mitochondrial capacityJournal of Cachexia Sarcopenia and Muscle · 2024
12. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human studyMolecular Cancer · 2023
13. Model Informed Development of SIM0295 in Patients with Gout and Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/ Pharmacodynamics ApproachExpert Opinion on Investigational Drugs · 2023
14. Is Leg-Driven Treadmill-Based Exoskeleton Robot Training Beneficial to Poststroke PatientsAmerican Journal of Physical Medicine & Rehabilitation · 2022
15. Exploring Conformational Preferences of Leu-enkephalin Using the Conformational Search and Double-Hybrid DFT Energy CalculationsACS Omega · 2022
16. Characteristics of histamine H4 receptor agonist-induced allergic conjunctivitis model in Guinea pigsJournal of Pharmacological and Toxicological Methods · 2022
17. Association of serum high-sensitivity C reactive protein with risk of mortality in an Asian population: the Health Examinees cohortBMJ Open · 2022
18. Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian CancerFrontiers in Oncology · 2022
19. Modified and Scalable Synthesis of N -Tosyl-4-ChlorobenzenesulfonimidoylFluoride (SulfoxFluor):Direct Imidation of Sulfinyl Chlorides with Chloramine-T TrihydrateOrganic Process Research & Development · 2022
20. Comparative Pharmacokinetics Between a Fixed‐Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male SubjectsClinical Pharmacology in Drug Development · 2022